MacroGenics, Inc. (MGNX)
4.14
+0.01
(+0.24%)
USD |
NASDAQ |
Sep 18, 16:00
4.14
0.00 (0.00%)
After-Hours: 20:00
MacroGenics Cash from Investing (Quarterly) : 27.96M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.96M |
| March 31, 2026 | 45.32M |
| December 31, 2025 | -65.99M |
| September 30, 2025 | -20.37M |
| June 30, 2025 | -37.64M |
| March 31, 2025 | 9.902M |
| December 31, 2024 | 41.47M |
| September 30, 2024 | 35.60M |
| June 30, 2024 | 47.44M |
| March 31, 2024 | 24.79M |
| December 31, 2023 | 38.82M |
| September 30, 2023 | -33.52M |
| June 30, 2023 | -113.48M |
| March 31, 2023 | 28.10M |
| December 31, 2022 | -5.788M |
| September 30, 2022 | 71.95M |
| June 30, 2022 | 23.04M |
| March 31, 2022 | -18.48M |
| December 31, 2021 | -13.55M |
| September 30, 2021 | -2.617M |
| June 30, 2021 | 13.82M |
| March 31, 2021 | -34.26M |
| December 31, 2020 | -16.08M |
| September 30, 2020 | -43.28M |
| June 30, 2020 | 41.01M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.56M |
| December 31, 2019 | 7.626M |
| September 30, 2019 | -6.372M |
| June 30, 2019 | -10.12M |
| March 31, 2019 | -70.49M |
| December 31, 2018 | 45.07M |
| September 30, 2018 | -0.006M |
| June 30, 2018 | -7.811M |
| March 31, 2018 | 19.39M |
| December 31, 2017 | 8.639M |
| September 30, 2017 | 4.464M |
| June 30, 2017 | 73.13M |
| March 31, 2017 | -8.357M |
| December 31, 2016 | 2.034M |
| September 30, 2016 | -3.163M |
| June 30, 2016 | -56.59M |
| March 31, 2016 | -12.53M |
| December 31, 2015 | -145.69M |
| September 30, 2015 | -2.608M |
| June 30, 2015 | -2.812M |
| March 31, 2015 | -0.997M |
| December 31, 2014 | -1.658M |
| September 30, 2014 | -0.672M |
| June 30, 2014 | -0.7947M |
| March 31, 2014 | -0.4473M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -10.35B |
| Xencor, Inc. | 85.12M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -40.75M |
| Cash from Financing (Quarterly) | 60.17M |
| Free Cash Flow | -65.54M |
| Free Cash Flow Per Share (Quarterly) | -0.6534 |
| Free Cash Flow to Equity (Quarterly) | -134.58M |
| Free Cash Flow to Firm (Quarterly) | -37.16M |
| Free Cash Flow Yield | -24.97% |